Literature DB >> 28005588

Chronic Hypertension in Pregnancy: Diagnosis, Management, and Outcomes.

Nana-Ama E Ankumah1, Baha M Sibai.   

Abstract

Chronic hypertension affects up to 5% of pregnancies. Women can be stratified into low-risk or high-risk chronic hypertension based on baseline laboratory and diagnostic work-up, comorbid conditions, and outcomes in prior pregnancies. Pregnancies complicated by chronic hypertension are at risk for increased adverse maternal and neonatal outcomes including superimposed preeclampsia, fetal growth restriction, placental abruption, and perinatal death. Mainstays of management include blood pressure control, close monitoring for development of superimposed preeclampsia, serial ultrasound assessment of fetal growth, and antenatal testing after 32 weeks.

Entities:  

Mesh:

Year:  2017        PMID: 28005588     DOI: 10.1097/GRF.0000000000000255

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  13 in total

1.  [A comparative study of cerebellar development between appropriate-for-gestational age infants and small-for-gestational-age infants].

Authors:  Ying Wang; Gui-Fang Li; Rui-Ke Liu; Li Li; Xue-Qian DU; Gui-Lian Li; Shuai Chen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

Review 2.  Preconception Counseling for Women With Cardiac Disease.

Authors:  Mark A Clapp; Sarah N Bernstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09

3.  Association of Unilateral Renal Agenesis With Adverse Outcomes in Pregnancy: A Matched Cohort Study.

Authors:  Jessica Kendrick; John Holmen; Zhiying You; Gerard Smits; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2017-04-07       Impact factor: 8.860

4.  Periconceptional 1,3-butanediol supplementation suppresses the superimposed preeclampsia-like phenotype in the Dahl salt-sensitive rat.

Authors:  Jeanne A Ishimwe; Melanie B Baker; Michael R Garrett; Jennifer M Sasser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-17       Impact factor: 4.733

5.  High blood pressure at entry into antenatal care and birth outcomes among a cohort of HIV-uninfected women and women living with HIV initiating antiretroviral therapy in South Africa.

Authors:  Angela M Bengtson; Tamsin K Phillips; Stanzi M le Roux; Kirsty Brittain; Allison Zerbe; Hlengiwe P Madlala; Thokozile R Malaba; Gregory Petro; Elaine J Abrams; Landon Myer
Journal:  Pregnancy Hypertens       Date:  2020-11-28       Impact factor: 2.899

6.  ACC-AHA Diagnostic Criteria for Hypertension in Pregnancy Identifies Patients at Intermediate Risk of Adverse Outcomes.

Authors:  Kristin C Darwin; Jerome J Federspiel; Brittany L Schuh; Ahmet A Baschat; Arthur J Vaught
Journal:  Am J Perinatol       Date:  2020-05-23       Impact factor: 1.862

7.  Postpartum Interventions to Reduce Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: A Systematic Review.

Authors:  Nicla A Lui; Gajana Jeyaram; Amanda Henry
Journal:  Front Cardiovasc Med       Date:  2019-11-15

8.  Resilience mediates the effect of self-efficacy on symptoms of prenatal anxiety among pregnant women: a nationwide smartphone cross-sectional study in China.

Authors:  Ruqing Ma; Fengzhi Yang; Lijuan Zhang; Kristin K Sznajder; Changqing Zou; Yajing Jia; Can Cui; Weiyu Zhang; Wenzhu Zhang; Ning Zou; Xiaoshi Yang
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-17       Impact factor: 3.007

9.  Early Pregnancy Blood Pressure Elevations and Risk for Maternal and Neonatal Morbidity.

Authors:  Elizabeth F Sutton; Sarah C Rogan; Samia Lopa; Danielle Sharbaugh; Matthew F Muldoon; Janet M Catov
Journal:  Obstet Gynecol       Date:  2020-07       Impact factor: 7.623

10.  Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy.

Authors:  Mamoru Morikawa; Emi Kato-Hirayama; Michinori Mayama; Yoshihiro Saito; Kinuko Nakagawa; Takeshi Umazume; Kentaro Chiba; Satoshi Kawaguchi; Kazuhiko Okuyama; Hidemichi Watari
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.